Abstract
Concomitant infections, which are common in patients who have received an organ transplant, must be diagnosed and treated early to prevent high mortality rates. We describe a case of concomitant Cytomegalovirus infection and Aspergillus pneumonia in a heart transplant patient who received pulsed steroids as therapy for rejection, and we describe the successful treatment of that coinfection with ganciclovir and voriconazole.
MeSH terms
-
Acute Disease
-
Antifungal Agents / therapeutic use*
-
Antiviral Agents / therapeutic use*
-
Cardiomyopathy, Dilated / surgery
-
Cytomegalovirus Infections / diagnosis*
-
Cytomegalovirus Infections / drug therapy
-
Cytomegalovirus Infections / virology
-
Early Diagnosis
-
Ganciclovir / therapeutic use
-
Graft Rejection / drug therapy*
-
Graft Rejection / immunology
-
Heart Transplantation / adverse effects*
-
Humans
-
Immunosuppressive Agents / administration & dosage
-
Immunosuppressive Agents / adverse effects*
-
Invasive Pulmonary Aspergillosis / diagnosis*
-
Invasive Pulmonary Aspergillosis / drug therapy
-
Invasive Pulmonary Aspergillosis / microbiology
-
Male
-
Middle Aged
-
Opportunistic Infections / diagnosis*
-
Opportunistic Infections / drug therapy
-
Opportunistic Infections / microbiology
-
Opportunistic Infections / virology
-
Pulse Therapy, Drug
-
Pyrimidines / therapeutic use
-
Tomography, X-Ray Computed
-
Treatment Outcome
-
Triazoles / therapeutic use
-
Voriconazole
Substances
-
Antifungal Agents
-
Antiviral Agents
-
Immunosuppressive Agents
-
Pyrimidines
-
Triazoles
-
Voriconazole
-
Ganciclovir